RBC Adjusts Perspective Therapeutics' PT to $27 From $29, Keeps Outperform Rating, Speculative Risk
RBC Adjusts Perspective Therapeutics' PT to $27 From $29, Keeps Outperform Rating, Speculative Risk
RBC将Perspective Therapeutics的目标价从29美元调整为27美元,维持强于大市评级,具有投机风险
Unity Software(U.US) reported fourth-quarter financial results after the market close on Monday. Here's a rundown of the report.Q4 Earnings: Unity said fourth-quarter revenue increased 35% year-over-year to $609 million, beating the consensus estimate of $562.71 million. The company reported a quarterly loss of 66 cents per share.
登录免费看全文
登录/注册